Imfinzi (durvalumab) - AstraZeneca
Padcev (enfortumab vedotin) - Seagen, Astellas
Yonsa (abiraterone acetate) - Churchill Pharma, Sun Pharma
Opdivo (nivolumab) - Ono Pharma, BMS
Xalkori (crizotinib) - Pfizer
eganelisib (IPI-549) - Infinity Pharma
Keytruda (pembrolizumab) - Merck (MSD)
Erleada (apalutamide) - J&J
Cabometyx (cabozantinib tablet) - Takeda, Exelixis, Ipsen
Sutent (sunitinib) - Pfizer
savolitinib (HMPL-504) - AstraZeneca, Chi-Med
https://www.practiceupdate.com/content/asco-gu-2021-recommendations-from-dr-shilpa-gupta/113167/7/1/3
 
Feb 7, 2021
 
Prev Next